Sen. John Hoeven (R-ND) bought $50K-$100K of CVS stock

John Hoeven, U.S. Senator (R-ND), disclosed a purchase of CVS Health Corporation (CVS) stock worth $50K-$100K in a STOCK Act filing on Jun 14, 2018.

The trade happened on Jun 7, 2018, 7 days before it was made public.

CVS has moved +37.7% since the trade date, from $65.02 to $89.52 (Nov 11, 2026 close).